Ianelli Christopher 4
4 · iSpecimen Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
iSpecimen Inc.ISPC
Ianelli Christopher
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Option
2023-01-06−845→ 10,000 totalExercise: $1.00Exp: 2023-01-22→ Common Stock (845 underlying) - Exercise/Conversion
Common Stock
2023-01-06$1.00/sh+845$845→ 425,359 total - Award
Option
2023-01-03$1.41/sh+10,000$14,100→ 10,845 totalExercise: $1.41Exp: 2033-01-03→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.
- [F2]Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.
- [F3]Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.
- [F4]Represents remaining granted stock options across all grants.